vMIP-II (1-21)

vMIP-II (1-21), a peptide sourced from viral macrophage inflammatory protein-II (vMIP-II), exhibits exclusive chemokine receptor antagonism by specifically engaging receptors implicated in immunological reactions. Its remarkable anti-inflammatory attributes make vMIP-II (1-21) a compelling candidate for biomedical investigations concerning the modulation of chemokine receptors across diverse pathological conditions, encompassing autoimmune maladies, inflammatory-linked malignancies, and viral afflictions.

Online Inquiry

CAT#GR2184
CAS265650-93-9
M.F/FormulaC108H169N33O27S
M.W/Mr.2425.84
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Histrelin acetate, sold under many brand name like Vantas, Supprelin LA and others, is a nonapeptide analog of g ...

 PAC-113, as well as a new type of Trp-rich peptide, is a 12 amino-acid fragment of the saliva protein histatin 5 ...

 Studies on the binding affinities of darifenacin hydrobromide and human muscarinic receptor subtypes show strong ...

 TC 14012 is a serum-stable derivative of the peptidomimetic T140, which is a cyclic peptide with the structure o ...

  st-Ht31, a protein kinase A (PKA)-anchoring inhibitor, greatly induces robust cholesterol or phospholipid effl ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.